Oceanaa Biotek Key Ratios

BSE: 538019

₹2.40

up-down-arrow-0.12 (-4.76%)

As on 23-May-2022IST

Market cap

info icon

₹3 Cr

Revenue (TTM)

info icon

₹22 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -74.49 -72.46 32.16 -20.10 -11.19
EBIT -688.98 -255.50 96.45 -143.79 11.63
Net Profit -832.83 -231.55 92.79 -160.07 22.41
EPS -832.67 -231.56 92.79 -154.63 15.62
Book Value -- -- 8.79 11.04 15.11
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-20Mar-19
EBIT-Margin info -5.731.28-3.3310.02-56.24
Net Margin info -9.52-2.85-6.748.63-55.26
Return on equity info -4.085.54-5.188.41-56.88
Return on Capital info 3.5615.03--9.52-56.03
Return on Assets info -2.773.64-3.445.53-40.26
Debt to Equity (x) info ----0.020.030.04
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
9.52
-56.03
57.20
31.89
Peer Median
--
13.99
25.14
30.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-5.18

Lower than Peers by 14.25

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
-5.18
8.41
-56.88
36.25
20.32
Peer Median
9.07
12.24
18.81
29.52
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-3.44

Lower than Peers by 7.72

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
-3.44
5.53
-40.26
26.44
13.19
Peer Median
4.28
6.12
11.61
11.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-3.33

Lower than Peers by 9.28

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
-3.33
10.02
-56.24
29.04
11.77
Peer Median
5.95
4.37
7.40
11.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-6.74

Lower than Peers by 9.52

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
-6.74
8.63
-55.26
18.07
7.54
Peer Median
2.78
5.50
6.46
5.82
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
17.07
-48.37
23.82
10.50
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

32.16

Higher than Peers by 10.07

Year on year growth in net sales

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
32.16
-29.29
-39.98
65.83
13.43
Peer Median
22.10
-6.29
-1.89
12.93
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

96.45

Higher than Peers by 68.48

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
96.45
112.59
-216.23
309.05
13.11
Peer Median
27.97
-42.82
-24.81
1,052.13
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

92.79

Higher than Peers by 66.46

Year on year growth in profit after tax

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
92.79
111.06
-283.36
297.73
26.30
Peer Median
26.34
-29.20
-27.37
131.76
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

92.79

Higher than Peers by 73.52

Year on year growth in earnings per share

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
92.79
111.06
-283.36
199.06
26.30
Peer Median
19.27
-29.20
-28.28
137.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
8.79
-44.16
199.76
26.11
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

0.02

Lower than Peers by 0.03

Total debt / Net worth

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
0.02
0.03
0.04
0.03
0.00
Peer Median
0.05
0.78
0.72
0.74
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
--
--
--
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.73

Lower than Peers by 0.03

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
1.73
1.60
1.75
2.75
2.33
Peer Median
1.76
1.50
1.56
1.60
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.64

Higher than Peers by 0.57

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
1.64
1.54
1.71
2.26
1.64
Peer Median
1.07
0.76
0.81
1.46
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-11.34

Lower than Peers by 13.87

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
-11.34
25.05
-121.91
24.52
121.65
Peer Median
2.53
7.52
11.16
8.36
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

37.15

Higher than Peers by 23.11

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
37.15
20.54
29.24
17.91
13.32
Peer Median
14.04
20.69
17.59
25.80
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.51

Lower than Peers by 0.79

Sales / Average Total Assets

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
0.51
0.64
0.73
1.46
1.76
Peer Median
1.30
1.30
1.80
2.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
112.91
107.81
47.33
36.82
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
9.19
35.01
34.20
47.93
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
127.72
41.72
48.75
81.13
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
-5.62
101.11
32.78
3.62
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
3.86
--
18.85
18.55
Peer Median
20.19
14.91
18.32
18.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.12

Lower than Peers by 2.18

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
0.12
0.31
1.30
4.56
3.38
Peer Median
2.30
1.48
2.50
3.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
--
--
--
0.99
1.20
Peer Median
--
--
0.58
0.36
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

3.16

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
3.16
1.92
-1.89
9.81
9.32
Peer Median
--
15.14
14.00
11.99
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

3

Lower than Peers by 268

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-20
Mar-19
Mar-18
Mar-17
Oceanaa Biotek
3
9
33
206
51
Peer Median
271
179
412
498
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...